S&P ASX All Technology

US Dollar vs AUD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

MGTA Magenta Therapeutics Inc

11.1936

0.00 (0.00%)

Last Updated: 11:00:00

Delayed by 15 minutes

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Article too big to display. Click here to view on the SEC website

Magenta Therapeutics (NASDAQ:MGTA)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more Magenta Therapeutics Charts.

Magenta Therapeutics (NASDAQ:MGTA)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more Magenta Therapeutics Charts.

Magenta Therapeutics Inc News

Form 424B3 - Prospectus [Rule 424(b)(3)]
Tuesday 17 September 2024 (4 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 17 September 2024 (4 months ago) • Edgar (US Regulatory)

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Friday 13 September 2024 (4 months ago) • Edgar (US Regulatory)

Form S-8 - Securities to be offered to employees in employee benefit plans
Friday 9 August 2024 (5 months ago) • Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Friday 9 August 2024 (5 months ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Friday 9 August 2024 (5 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 9 August 2024 (5 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 6 June 2024 (7 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 29 May 2024 (8 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 29 May 2024 (8 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 29 May 2024 (8 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 29 May 2024 (8 months ago) • Edgar (US Regulatory)

More Magenta Therapeutics Inc News Articles

Societe Generale Effekten

Walls & Futures REIT

Societe Generale Effekten

Grupo Mateus ON

Invesco Ftse Rafi Us 100...

Intesa Sanpaolo

Vontobel Financial Produ...

Ssga Spdr Etfs Europe I ...

Societe Generale Effekten

Vontobel Financial Produ...

Vontobel Financial Produ...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions